SCHEMBL2396989

SCHEMBL2396989

COc1cncc(-c2ccc3nc(Nc4cccc(NC5CCC(O)CC5)n4)sc3n2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CG P48736 2/20 0.49
ITK Q08881 9/20 0.47
LCK P06239 8/20 0.47
AURKB Q96GD4 6/20 0.47
FYN P06241 1/20 0.46
PIK3CD O00329 1/20 0.44
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
BRAF P15056 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
HSP90AA1 P07900 1/20 0.39
CLK2 P49760 1/20 0.38
CLK3 P49761 1/20 0.38
DYRK1A Q13627 1/20 0.38
SYK P43405 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2396976 1.00 PIK3CG (0.49) PIK3CGITKLCKAURKBFYN
SCHEMBL12291555 0.91 PIK3CD (0.43) PIK3CGITKLCKAURKBFYN
SCHEMBL2401269 0.85 PIK3CD (0.60) PIK3CGITKLCKAURKBFYN
SCHEMBL2401283 0.85 PIK3CD (0.60) PIK3CGITKLCKAURKBFYN
SCHEMBL2397731 0.83 ITK (0.50) ITKLCKAURKBIRAK4EGFR
SCHEMBL2397725 0.83 ITK (0.50) ITKLCKAURKBIRAK4EGFR
SCHEMBL2395099 0.82 ITK (0.43) ITKLCKAURKBCLK2CLK3
SCHEMBL2395088 0.82 ITK (0.43) ITKLCKAURKBCLK2CLK3
SCHEMBL2396521 0.80 DYRK1A (0.41) ITKLCKAURKBDYRK1AIRAK4
Trifluoroacetic Acid SCHEMBL2370610 0.79 IRAK4 (0.41) ITKLCKAURKBBRAFCLK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011110575-A1 DERIVATIVES OF 2-[2-(BENZO- OR PYRIDO-) THIAZOLYLAMINO]-6-AMINOPYRIDINE, USEFUL IN THE TREATMENT OF RESPIRATORIC, ALLERGIC OR INFLAMMATORY DISEASES GLAXO GROUP LIMITED (GB) 2011-09-15 WO disclosed